AstraZeneca vaccine and Guillain-Barré syndrome: There’s minimal cause for concern
Genes associated with COVID-19 risk identified
14 May 2021Early biomarker warning of heart disease for diabetic patients
14 May 2021AstraZeneca vaccine and Guillain-Barré syndrome: There’s minimal cause for concern
The Therapeutic Goods Administration (TGA) yesterday revealed there have been six reports of Guillain-Barré syndrome in Australia following the AstraZeneca COVID vaccine.
